(MedPage Today) -- WASHINGTON -- Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study…
Catherina Anderson dedicated her life to supporting people during some of their most difficult moments as both a critical care and hospice nurse, but her outlook on life was forever changed when the roles reversed and she became the…
Minister of Finance and Coordinating Minister of the Economy, Mr. Wale Edun, has praised the Medicaid Cancer Foundation for its ₦100 million disbursement to cancer patients and support organizations, describing it as a model of private…
A growing number of people are filing complaints to Ontario's patient ombudsman office, including a person discharged by a hospital without being told they had cancer.
A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to "scan" the molecular features of each patient's cancer. Published in Cell Reports Medicine, CAN-Scan…
A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a critical factor contributing to the failure…
Medications like Wegovy and Ozempic, known for managing diabetes and promoting weight loss, may also be linked to significantly lower death rates in colon cancer patients, according to a new study cited by the Independent . Researchers at…
Hundreds more people with an aggressive form of blood cancer can now be offered hope of a cure and “a new lease of life” from today thanks to an NHS drug rollout. Glofitamab (Columvi®) will now be offered to around 300 people a year with…
Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
The Medicaid Cancer Foundation (MCF) has disbursed N100 million to support cancer patients across the country as part of its ongoing commitment to improve access to care and reduce the burden of cancer treatment in the country. Speaking…
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see their cancer…
Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these tests are now rapidly being adopted across…
The Medicaid Cancer Foundation has disbursed ₦100m to 60 cancer patients across Nigeria to support their treatment under its Access to Care initiative. According to a statement issued by the foundation on Tuesday, the disbursement was…